These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1324142)

  • 1. Gastrointestinal transit times of radiolabeled meal in progressive systemic sclerosis.
    Madsen JL; Hendel L
    Dig Dis Sci; 1992 Sep; 37(9):1404-8. PubMed ID: 1324142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal transit of technetium-99m-labeled cellulose fiber and indium-111-labeled plastic particles.
    Madsen JL; Jensen M
    J Nucl Med; 1989 Mar; 30(3):402-6. PubMed ID: 2738668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cisapride on gastrointestinal transit in healthy humans.
    Madsen JL
    Dig Dis Sci; 1990 Dec; 35(12):1500-4. PubMed ID: 2253536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of gender, age, and body mass index on gastrointestinal transit times.
    Madsen JL
    Dig Dis Sci; 1992 Oct; 37(10):1548-53. PubMed ID: 1396002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal transit through esophagus, stomach, small and large intestine in patients with progressive systemic sclerosis.
    Wegener M; Adamek RJ; Wedmann B; Jergas M; Altmeyer P
    Dig Dis Sci; 1994 Oct; 39(10):2209-15. PubMed ID: 7924744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of bran, ispaghula, and inert plastic particles on gastric emptying and small bowel transit in humans: the role of physical factors.
    McIntyre A; Vincent RM; Perkins AC; Spiller RC
    Gut; 1997 Feb; 40(2):223-7. PubMed ID: 9071936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metoclopramide response in patients with progressive systemic sclerosis. Effect on esophageal and gastric motility abnormalities.
    Johnson DA; Drane WE; Curran J; Benjamin SB; Chobanian SJ; Karvelis K; Cattau EL
    Arch Intern Med; 1987 Sep; 147(9):1597-601. PubMed ID: 3632168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities of esophageal and gastric emptying in progressive systemic sclerosis.
    Maddern GJ; Horowitz M; Jamieson GG; Chatterton BE; Collins PJ; Roberts-Thomson P
    Gastroenterology; 1984 Oct; 87(4):922-6. PubMed ID: 6468880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of various prokinetic drugs on gastrointestinal transit times in patients with progressive systemic scleroderma].
    Folwaczny C; Läritz M; Meurer M; Endres SP; König A; Schindlbeck N
    Z Gastroenterol; 1997 Oct; 35(10):905-12. PubMed ID: 9432812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simplified scintigraphic methods for measuring gastrointestinal transit times.
    Graff J; Brinch K; Madsen JL
    Clin Physiol; 2000 Jul; 20(4):262-6. PubMed ID: 10886257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scintigraphic measurement of regional gut transit in idiopathic constipation.
    Stivland T; Camilleri M; Vassallo M; Proano M; Rath D; Brown M; Thomforde G; Pemberton J; Phillips S
    Gastroenterology; 1991 Jul; 101(1):107-15. PubMed ID: 2044899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gastrointestinal involvement in progressive systemic scleroderma].
    Folwaczny C; Rothfuss U; Riepl RL; Lehnert P; Bloching H; Meurer M; Karbach U
    Z Gastroenterol; 1995 Nov; 33(11):654-61. PubMed ID: 8600662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disturbed gastric and small bowel transit in severe idiopathic constipation.
    van der Sijp JR; Kamm MA; Nightingale JM; Britton KE; Granowska M; Mather SJ; Akkermans LM; Lennard-Jones JE
    Dig Dis Sci; 1993 May; 38(5):837-44. PubMed ID: 8482182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid and opioid-like drug effects on whole-gut transit measured by scintigraphy.
    Maurer AH; Krevsky B; Knight LC; Brown K
    J Nucl Med; 1996 May; 37(5):818-22. PubMed ID: 8965152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esophageal scintigraphy with a semisolid meal to evaluate esophageal dysmotility in systemic sclerosis and Raynaud's phenomenon.
    Bestetti A; Carola F; Conciato L; Marasini B; Tarolo GL
    J Nucl Med; 1999 Jan; 40(1):77-84. PubMed ID: 9935061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bran particle size on gastric emptying and small bowel transit in humans: a scintigraphic study.
    Vincent R; Roberts A; Frier M; Perkins AC; MacDonald IA; Spiller RC
    Gut; 1995 Aug; 37(2):216-9. PubMed ID: 7557571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards a less costly but accurate test of gastric emptying and small bowel transit.
    Camilleri M; Zinsmeister AR; Greydanus MP; Brown ML; Proano M
    Dig Dis Sci; 1991 May; 36(5):609-15. PubMed ID: 2022162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal motility disorder assessment in systemic sclerosis.
    Savarino E; Mei F; Parodi A; Ghio M; Furnari M; Gentile A; Berdini M; Di Sario A; Bendia E; Bonazzi P; Scarpellini E; Laterza L; Savarino V; Gasbarrini A
    Rheumatology (Oxford); 2013 Jun; 52(6):1095-100. PubMed ID: 23382360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human gastric emptying and colonic filling of solids characterized by a new method.
    Camilleri M; Colemont LJ; Phillips SF; Brown ML; Thomforde GM; Chapman N; Zinsmeister AR
    Am J Physiol; 1989 Aug; 257(2 Pt 1):G284-90. PubMed ID: 2764112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease.
    Gerbracht DD; Steen VD; Ziegler GL; Medsger TA; Rodnan GP
    Arthritis Rheum; 1985 Jan; 28(1):87-92. PubMed ID: 3871330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.